(-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity

M. Barthelman, W. B. Bair, K. K. Stickland, W. Chen, B. N. Timmermann, S. Valcic, Z. Dong, G. T. Bowden

Research output: Contribution to journalArticlepeer-review

132 Scopus citations


Green tea polyphenols have been shown to inhibit cancer in a variety of tumor models, including ultraviolet B (UVB)-induced non-melanoma skin cancer. In green tea extracts, the major dry mass constituent is the family of catechins, of which (-)-epigallocatechin-(3)-gallate (EGCG) is considered to be important for the chemopreventive activity. EGCG has been shown to have antioxidant properties, but there has been little progress toward identifying the specific targets and mechanisms of its action. Using cultured human keratinocytes, we show that UVB-induced AP-1 activity is inhibited by EGCG in a dose range of 5.45 nM to 54.5 μM. EGCG is effective at inhibiting AP-1 activity when applied before, after or both before and after UVB irradiation. EGCG also inhibits AP-1 activity in the epidermis of a transgenic mouse model. This work begins to define a mechanism by which EGCG could be acting to inhibit UVB-induced tumor formation.

Original languageEnglish (US)
Pages (from-to)2201-2204
Number of pages4
Issue number12
StatePublished - 1998
Externally publishedYes


Dive into the research topics of '(-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity'. Together they form a unique fingerprint.

Cite this